Abstracts

Abstract.jpg

The call for abstracts for World Cancer Congress 2024 has now closed. Thank you to all those who have submitted. Notification of the Abstract Committee's decisions in respect of submissions will be sent to all submitters by 24 May 2024.

 


NOMINATIONS FOR UICC Awards

The UICC Awards aim to recognize outstanding achievements and innovative practices from across the global cancer community. 

The three abstracts with the highest scores from each category will be shortlisted prior to the event and highlighted in the Congress promotional campaign. The winner from each list will be presented with an award at the World Cancer Congress in Geneva. 

 

ONSITE ABSTRACT HUB

The onsite Abstract Hub at the Congress venue in Geneva will serve as a dynamic area for informal networking and exchange, where attendees will have the opportunity to explore the entire abstract programme via our user-friendly consultation pods. All accepted abstracts will appear here (subject to accepted abstract authors registering to attend the Congress either in person or virtually by latest 5 July 2024). 

The onsite abstract hub is kindly supported by ASCO. 

ASCO Logo

 

ABSTRACT e-LIBRARY

All abstracts accepted for the World Cancer Congress 2024 abstract programme will appear in our new Abstract eLibrary (subject to accepted abstract authors registering to attend the Congress either in person or virtually by latest 5 July 2024). The online abstract library will offer attendees and abstract submitters a fresh, modern, intuitive interface via which to explore the abstract programme. 

 

international journal of cancer -  SUPPLEMENT

The International Journal of Cancer (IJC) will publish the 200 highest-scoring abstracts from the World Cancer Congress 2024 in a dedicated IJC supplement. The International Journal of Cancer is the official journal of the Union for International Cancer Control and is an international renown peer-reviewed journal with a global readership. The IJC receives over 3,000 submissions a year under a broad scope of topics relevant to experimental and clinical cancer research. This supplement of the IJC will include selected abstracts submitted in the areas of scientific studies, advocacy, policy and practice, and fundraising and presents a fantastic opportunity to researchers to have their work recognized in a leading international medical journal.
 

Formats of presentation

All accepted abstracts will be available in the abstract eLibrary hosted on the dedicated Congress online platform.

By 24 May, all submitters will be notified of the format of the presentation of their accepted abstract. The selection is based on the average score received. As a result, some abstracts and summary reports will be presented in person at the World Cancer Congress under one of the following presentation formats:

  1. Abstract oral: 8-minute in-person presentation (incl. 2 minutes of Questions and Answers from the in-person audience). Abstract oral presentations are part of a larger session and will be scheduled for presentation in front of an audience of up to 80 people.
    Before 5 July:
    ​​​​Abstract presenters from this category must purchase a registration to attend the Congress in person in Geneva.
     
  2. Rapid Fire: 3-minute presentation in front of an audience of up to 80 people.
    Before 5 July:
    Abstract presenters from this category must purchase a registration to present at the Congress in person in Geneva. In addition to the on-site presentation, the accepted abstract will be part of the abstract eLibrary available on the online platform, and for self-consultation in the Theme Pavillions of the Global Village.
  3. Inclusion in the abstract eLibrary + meeting facility: The abstract eLibrary will be hosted on the online platform.
    Before 5 July, submitters and authors who wish to have their accepted abstracts appear in the abstract eLibrary will need to either purchase a registration if they wish to attend the Congress in-person in Geneva, or a digital access if they cannot travel to Geneva and only wish to only have their abstract available in the abstract eLibrary. 

    Connect pro-actively: UICC would like to encourage useful connections and new collaborations amongst participants. All submitters are invited to use the online platform to set-up meetings with other participants to present their work to them. Meetings can be set-up and conducted virtually either directly through the online platform or in-person in Geneva, in one of the lounge areas of the Congress. 

Review Process and Timeline

The review process is based on an independent two-tier review process from the Congress Abstract Committee and an international panel of health experts.

  • 31 January – 4 April 2024: Call for Abstracts & Ongoing Abstract Review Phase 1

The Abstract Committee screens submissions, and all submitters are notified if the abstract is accepted or rejected.

  • 10 April – 10 May 2024: Abstract Review Phase 2

The Abstract Committee, supported by a selected panel of 130+ experts, scores accepted abstracts.

  • 24 May 2024: Notification of presentation format and time slot to all accepted abstract submitters
     
  • 5 July 2024: All abstract presenters confirmed with a full registration or digital pass for inclusion in the abstract eLibrary.

 

For any questions regarding the abstracts, please contact John Lawlor at lawlor@uicc.org. Thank you!

8 May 2024